Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer.
白细胞介素-6/C反应蛋白水平升高与腺苷通路上调有关，可作为非小细胞肺癌对基于免疫检查点抑制剂的疗法产生耐药性的潜在标志物
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-007310
Naqash Abdul Rafeh, McCallen Justin D, Mi Emma, Iivanainen Sanna, Marie Mona A, Gramenitskaya Daria, Clark James, Koivunen Jussi Pekka, Macherla Shravanti, Jonnalagadda Sweta, Polsani Shanker, Jiwani Rahim Ali, Hafiz Maida, Muzaffar Mahvish, Brunetti Leonardo, Stroud Chipman R G, Walker Paul R, Wang Kun, Chung Youngmin, Ruppin Eytan, Lee Se-Hoon, Yang Li V, Pinato David J, Lee Joo Sang, Cortellini Alessio
